Atrial fibrillation/flutter and Macular ischaemia

Summary:

Macular ischaemia is found among people with Atrial fibrillation/flutter, especially for people who are male, 60+ old.

The study analyzes which people have Macular ischaemia with Atrial fibrillation/flutter. It is created by eHealthMe based on reports of 6 people who have Atrial fibrillation/flutter from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Atrial fibrillation/flutter?

Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles) is found to be associated with 2,386 drugs and 3,837 conditions by eHealthMe. Check the latest studies of Atrial fibrillation/flutter.

What is Macular ischaemia?

Macular ischaemia (broken foveal capillary ring) is found to be associated with 7 drugs and 91 conditions by eHealthMe. Check the latest studies of Macular ischaemia.

On Apr, 09, 2026

6 people who have Atrial Fibrillation/Flutter and Macular Ischaemia are studied.

Would you have Macular ischaemia when you have Atrial fibrillation/flutter?

Gender of people who have Atrial Fibrillation/Flutter and experienced Macular Ischaemia *:

female: 0.0 %
male: 100 %

Age of people who have Atrial Fibrillation/Flutter and experienced Macular Ischaemia *:

Common co-existing conditions for these people *:

Platelet Disorder: 6 people, 100.00%
High Blood Pressure: 6 people, 100.00%

Common drugs taken by these people *:

Xarelto: 6 people, 100.00%
Rivaroxaban: 6 people, 100.00%
Acetylsalicylic Acid: 6 people, 100.00%
Clopidogrel: 4 people, 66.67%

Common symptoms for these people *:

Speech Impairment (Adult) (inability to speak (adult)): 6 people, 100.00%
Paresis Cranial Nerve (a condition of muscular weakness due to cranial nerve): 6 people, 100.00%
Ophthalmoplegia (a paralysis or weakness of one or more of the muscles that control eye movement): 6 people, 100.00%
Movement - Uncoordinated: 6 people, 100.00%
Hemiparesis (weakness on one side of the body): 6 people, 100.00%
Facial Paresis (weakness in facial muscle movement): 6 people, 100.00%
Dyskinesia (abnormality or impairment of voluntary movement): 6 people, 100.00%
Dizziness: 6 people, 100.00%
Diplopia (double vision): 6 people, 100.00%
Brain Stem Infarction (brainstem stroke): 6 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Macular ischaemia?

- Check whether Macular ischaemia is associated with a drug or a condition

Related publications that referenced our studies

Saleh M, Bourcier T, Noel G, Speeg-Schatz C, Gaucher D, "Bilateral macular ischemia and severe visual loss following trastuzumab therapy", Acta Oncologica, 2011 Apr .
Saleh M, Bourcier T, Noel G, Speeg-Schatz C, Gaucher D, "Bilateral macular ischemia and severe visual loss following trastuzumab therapy", Acta Oncologica, 2011 Apr .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Macular ischaemia and Atrial fibrillation/flutter, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.